Breast cancer clinical trial participation among diverse patients at a comprehensive cancer center

Emily L Podany; Shaun Bulsara; Katherine Sanchez; Kristen Otte; Matthew J Ellis; Maryam Kinik

doi:10.1038/s41523-024-00672-0

Breast cancer clinical trial participation among diverse patients at a comprehensive cancer center

NPJ Breast Cancer. 2024 Aug 3;10(1):70. doi: 10.1038/s41523-024-00672-0.

Authors

Emily L Podany^{1

2}, Shaun Bulsara³, Katherine Sanchez³, Kristen Otte³, Matthew J Ellis^{3

4}, Maryam Kinik³

Affiliations

¹ Baylor College of Medicine, Lester and Sue Smith Breast Center, Houston, TX, USA. [email protected].
² Washington University in St. Louis, St. Louis, MO, USA. [email protected].
³ Baylor College of Medicine, Lester and Sue Smith Breast Center, Houston, TX, USA.
⁴ The Institute for Proteogenomic Discovery, Houston, TX, USA.

Abstract

This study was designed to determine the enrollment patterns in breast cancer clinical trials (CCTs) of patients with diverse backgrounds in an equal access setting and to evaluate the factors contributing to low rates of clinical trial accrual in patients of low socioeconomic status (SES). We performed a retrospective review of a prospectively maintained database of new patients seen at the Dan L. Duncan Comprehensive Cancer Center dating from 5/2015 to 9/2021, which included 3043 patients screened for breast CCTs. We compared the rate of CCT availability, eligibility, and enrollment between two patient populations: Smith Clinic, where most patients are of low SES and uninsured, and Baylor St. Luke's Medical Center (BSLMC) with mostly predominantly insured, higher income patients. We performed logistic regression to evaluate whether differences in age, clinic, race, trial type, and primary language may be underlying the differences in CCT enrollment. More patients were eligible for CCTs at Smith Clinic (53.7% vs 44.7%, p < 0.001). However, Smith Clinic patients were more likely to decline CCT enrollment compared to BSLMC (61.3% declined vs 39.4%, p < 0.001). On multivariate analysis, Black patients had a significantly higher rate of CCT refusal overall (OR = 0.26, 95% CI 0.12-0.56, p < 0.001) and BSLMC only (OR = 0.20, 95% CI 0.060-0.60, p = 0.006). Our data shows that it is likely an oversimplification to assume that equal access will lead to the elimination of CCT disparities. Efforts to diversify CCTs must include consideration of structural and institutional inequities as well as social needs.